Women with inflammatory bowel disease (IBD) have similar rates of fertility to the general
population, but have an increased rate of adverse pregnancy outcomes compared with the …

The aim of this article is to critically review available data regarding the safety of
immunomodulators and biological therapies during pregnancy and breast-feeding in women …

Discussion This is the second case report of the use of maintenance adalimumab during
pregnancy and the first reported use of adalimumab to treat Crohn's disease involving an …

2274 Letters to the Editor AJG–Vol. 96, No. 7, 2001 infusion was not given. The patient had
received her second infliximab infusion 4 wk prior and her first infusion 6 wk prior. The …

Introduction Inflammatory bowel disease often affects women during their reproductive
years, causing management concerns for obstetricians caring for these patients during …

Inflammatory bowel disease (IBD) often affects women around the age of conception and
pregnancy. Most drugs used to treat IBD are safe in pregnancy, but physicians must …

Inflammatory bowel disease (IBD) poses complex issues in pregnancy, but with high-quality
care excellent pregnancy outcomes are achievable. In this article, we review the current …

OBJECTIVES: We described pregnancy outcomes in Crohn's disease (CD) patients enrolled
in the TREAT Registry who received infliximab before, or during pregnancy and those not …

To the Editor: Tumor necrosis factor (TNF) is recognized as an important cytokine in the
pathogenesis of Crohn_s disease (CD), and TNF blockade has been effective in the …

Background & Aims The management of inflammatory bowel disease (IBD) poses a
particular challenge during pregnancy because the health of both the mother and the fetus …